By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swiss molecular diagnostics developer Diagnoplex today said it has closed a Series A financing extension with Debiopharm Group.

Diagnoplex said today that Debiopharm has committed to invest “a substantial amount” in the company, depending on certain milestones, and has provided half of that commitment up front, although the company did not provide specific financial details about the investment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.